<html>




<!-- Mirrored from www.iuns.org/features/executive_summary.htm by HTTrack Website Copier/3.x [XR&CO'2010], Wed, 11 Jan 2012 10:10:34 GMT -->
<head>

<meta http-equiv="Content-Language" content="en-us">

<meta name="GENERATOR" content="Microsoft FrontPage 5.0">

<meta name="ProgId" content="FrontPage.Editor.Document">

<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">

<title>Executive Summary of a Report to ICSU</title>

<style>

<!--

div.Section1

	{page:Section1;

	}

div.Section2

	{page:Section2;

	}

span.MsoFootnoteReference

	{vertical-align:super}

-->

</style>

<meta name="Microsoft Theme" content="nature-iuns 111, default">

<meta name="Microsoft Border" content="tlb, default">

</head>



<body background="../_themes/nature-iuns/nabkgnd.jpg" bgcolor="#FFFFCC" text="#000080" link="#990033" vlink="#006633" alink="#FF0000"><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica">



<p align="left"><font size="6"><strong>

<img border="0" src="../images/IUNS_logo%204-22.gif" align="left" width="90" height="135"><img src="_derived/executive_summary.htm_cmp_nature-iuns110_bnr.gif" width="660" height="65" border="0" alt="Executive Summary of a Report to ICSU"></strong></font><br>

<a href="../index.html"><img src="../_derived/home_cmp_nature-iuns110_gbtn.gif" width="120" height="20" border="0" alt="Home" align="middle"></a> <a href="../features.htm"><img src="../_derived/up_cmp_nature-iuns110_gbtn.gif" width="120" height="20" border="0" alt="Up" align="middle"></a></p>



<!--mstheme--></font></td></tr><!--msnavigation--></table><!--msnavigation--><table dir="ltr" border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td valign="top" width="1%"><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica">



<p>



<br>



<script language="JavaScript"><!--
MSFPhover = 
  (((navigator.appName == "Netscape") && 
  (parseInt(navigator.appVersion) >= 3 )) || 
  ((navigator.appName == "Microsoft Internet Explorer") && 
  (parseInt(navigator.appVersion) >= 4 ))); 
function MSFPpreload(img) 
{
  var a=new Image(); a.src=img; return a; 
}
// --></script><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav1n=MSFPpreload("../_derived/home_cmp_nature-iuns110_vbtn.gif"); MSFPnav1h=MSFPpreload("../_derived/home_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../index.html" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1h.src" onmouseout="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1n.src"><img src="../_derived/home_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Home" name="MSFPnav1"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav2n=MSFPpreload("../_derived/up_cmp_nature-iuns110_vbtn.gif"); MSFPnav2h=MSFPpreload("../_derived/up_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../features.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2h.src" onmouseout="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2n.src"><img src="../_derived/up_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Up" name="MSFPnav2"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav3n=MSFPpreload("../_derived/messages-from.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav3h=MSFPpreload("../_derived/messages-from.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../messages-from.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav3'].src=MSFPnav3h.src" onmouseout="if(MSFPhover) document['MSFPnav3'].src=MSFPnav3n.src"><img src="../_derived/messages-from.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Messages from..." name="MSFPnav3"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav4n=MSFPpreload("../_derived/activities.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav4h=MSFPpreload("../_derived/activities.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../activities.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav4'].src=MSFPnav4h.src" onmouseout="if(MSFPhover) document['MSFPnav4'].src=MSFPnav4n.src"><img src="../_derived/activities.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Activity Highlights" name="MSFPnav4"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav5n=MSFPpreload("../_derived/conferences.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav5h=MSFPpreload("../_derived/conferences.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../conferences.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav5'].src=MSFPnav5h.src" onmouseout="if(MSFPhover) document['MSFPnav5'].src=MSFPnav5n.src"><img src="../_derived/conferences.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Important Events" name="MSFPnav5"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav6n=MSFPpreload("../_derived/fellowships.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav6h=MSFPpreload("../_derived/fellowships.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../fellowships.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav6'].src=MSFPnav6h.src" onmouseout="if(MSFPhover) document['MSFPnav6'].src=MSFPnav6n.src"><img src="../_derived/fellowships.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Fellowships" name="MSFPnav6"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav7n=MSFPpreload("../_derived/mission.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav7h=MSFPpreload("../_derived/mission.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../mission.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav7'].src=MSFPnav7h.src" onmouseout="if(MSFPhover) document['MSFPnav7'].src=MSFPnav7n.src"><img src="../_derived/mission.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Mission" name="MSFPnav7"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav8n=MSFPpreload("../_derived/history.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav8h=MSFPpreload("../_derived/history.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../history.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav8'].src=MSFPnav8h.src" onmouseout="if(MSFPhover) document['MSFPnav8'].src=MSFPnav8n.src"><img src="../_derived/history.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="History" name="MSFPnav8"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav9n=MSFPpreload("../_derived/policy.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav9h=MSFPpreload("../_derived/policy.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../policy.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav9'].src=MSFPnav9h.src" onmouseout="if(MSFPhover) document['MSFPnav9'].src=MSFPnav9n.src"><img src="../_derived/policy.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Policy" name="MSFPnav9"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav10n=MSFPpreload("../_derived/recognitions.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav10h=MSFPpreload("../_derived/recognitions.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../recognitions.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav10'].src=MSFPnav10h.src" onmouseout="if(MSFPhover) document['MSFPnav10'].src=MSFPnav10n.src"><img src="../_derived/recognitions.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Recognitions" name="MSFPnav10"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav11n=MSFPpreload("../_derived/officers.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav11h=MSFPpreload("../_derived/officers.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../officers.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav11'].src=MSFPnav11h.src" onmouseout="if(MSFPhover) document['MSFPnav11'].src=MSFPnav11n.src"><img src="../_derived/officers.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Officers &amp; Council" name="MSFPnav11"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav12n=MSFPpreload("../_derived/taskforces.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav12h=MSFPpreload("../_derived/taskforces.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../taskforces.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav12'].src=MSFPnav12h.src" onmouseout="if(MSFPhover) document['MSFPnav12'].src=MSFPnav12n.src"><img src="../_derived/taskforces.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Task Forces" name="MSFPnav12"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav13n=MSFPpreload("../_derived/adhering-bodies.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav13h=MSFPpreload("../_derived/adhering-bodies.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../adhering-bodies.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav13'].src=MSFPnav13h.src" onmouseout="if(MSFPhover) document['MSFPnav13'].src=MSFPnav13n.src"><img src="../_derived/adhering-bodies.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Adhering Bodies" name="MSFPnav13"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav14n=MSFPpreload("../_derived/affiliated-bodies.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav14h=MSFPpreload("../_derived/affiliated-bodies.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../affiliated-bodies.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav14'].src=MSFPnav14h.src" onmouseout="if(MSFPhover) document['MSFPnav14'].src=MSFPnav14n.src"><img src="../_derived/affiliated-bodies.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Affiliated Bodies" name="MSFPnav14"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav15n=MSFPpreload("../_derived/nutrition_journals.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav15h=MSFPpreload("../_derived/nutrition_journals.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../nutrition_journals.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav15'].src=MSFPnav15h.src" onmouseout="if(MSFPhover) document['MSFPnav15'].src=MSFPnav15n.src"><img src="../_derived/nutrition_journals.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Nutrition Journals" name="MSFPnav15"></a><br><script language="JavaScript"><!--
if(MSFPhover) { MSFPnav16n=MSFPpreload("../_derived/links.htm_cmp_nature-iuns110_vbtn.gif"); MSFPnav16h=MSFPpreload("../_derived/links.htm_cmp_nature-iuns110_vbtn_a.gif"); }
// --></script><a href="../links.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav16'].src=MSFPnav16h.src" onmouseout="if(MSFPhover) document['MSFPnav16'].src=MSFPnav16n.src"><img src="../_derived/links.htm_cmp_nature-iuns110_vbtn.gif" width="140" height="60" border="0" alt="Links" name="MSFPnav16"></a></p>



<!--mstheme--></font></td><td valign="top" width="24"></td><!--msnavigation--><td valign="top"><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica">

  <h1>Genetically Modified Foods for Human Health and Nutrition: The 

    Scientific Basis for Benefit/Risk Assessment</h1>

  <!--msthemeseparator--><p align="center"><img src="../_themes/nature-iuns/anarule.gif" width="600" height="10"></p>

  <h2><!--mstheme--><font color="#008000">Executive Summary of a report to the <br>

  International Council for Science (ICSU)<br>

  prepared by an international group of <br>

  experts under the aegis of the <br>

  International Union of Nutritional Sciences (IUNS) and the International Union 

  for Toxicology (IUTOX).<!--mstheme--></font></h2>

  <p align="right"><b>July 2002</b></p>

  <!--msthemeseparator--><p align="center"><img src="../_themes/nature-iuns/anarule.gif" width="600" height="10"></p>

  <p class="iehbody">T<span lang="EN-GB">he International Council for Science (ICSU) 

  is a non-governmental organization, whose mission is to strengthen 

  international science for the benefit of society. The ICSU membership includes 

  both national science academies (98 members) and international science unions 

  (26 members). The combined expertise from these two groups enables ICSU to 

  address major international, interdisciplinary issues beyond the scope of 

  individual organizations. The topic of this monograph – Genetically Modified 

  Foods – is one such issue. It is an issue where science and society must come 

  together, both internationally and at a local level, and agree a way forward. 

  It is also an area where there are strongly conflicting views and opinions, 

  where scientific evidence and individual morals and beliefs are often opposed 

  and where the science itself is sometimes uncertain and open to selective 

  interpretation. However, food security is one of the major challenges facing 

  humanity and, as the new genetic technologies have potential to ameliorate the 

  current situation, whereby some 850 million people lack access to sufficient 

  nutritious food at affordable prices, the scientific community has a duty to 

  develop and explain its research in this area.</span></p>

  <p class="iehbody"><span lang="EN-GB">It is with this in mind that ICSU agreed 

  to fund the production of this monograph when it received a grant application 

  from several of its member unions and interdisciplinary scientific committees 

  in 2000. This project complements other work being carried out under the aegis 

  of ICSU’s Advisory Committee on Genetic Experimentation and Biotechnology (ACOGEB), 

  including a summary report on Biotechnology and Sustainable Development, which 

  has been prepared for the World Summit on Sustainable Development in 

  August/September 2002. ACOGEB has also commissioned a meta-analysis of the key 

  findings in recent reviews of genetically modified foods and crops that have 

  been conducted by various national, international and private agencies within 

  the past three years; the results of this will be available at

  <a href="../../external.html?link=http://www.icsu.org/" style="color: blue; text-decoration: underline; text-underline: single">

  www.icsu.org</a> in October 2002. The combined aim of these three activities 

  is to describe clearly and objectively the key issues relating to genetically 

  modified foods and agriculture from a scientific perspective. They should then 

  provide a solid basis on which to engage in constructive dialogue and to 

  develop responsibly the international research agenda in this area. </span>

  </p>

  <p class="MsoNormal"><span lang="EN-GB">Carthage Smith<br>

  Deputy Executive Director<br>

  ICSU</span></p>

  <!--mstheme--></font><table border="1" cellpadding="3" cellspacing="3" style="border-collapse: collapse" width="100%" id="AutoNumber1" bordercolordark="#006633" bordercolorlight="#339966">

    <tr>

      <td width="100%" bgcolor="#C0C0C0"><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica">Financial support has been provided by the International Council for Science 

    (ICSU) and the secretariat has been provided by the MRC Institute for 

    Environment and Health (Leicester, UK)<br>

    &nbsp;<!--mstheme--></font></td>

    </tr>

</table><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica"><!--msthemeseparator--><p align="center"><img src="../_themes/nature-iuns/anarule.gif" width="600" height="10"></p>

  <h3><!--mstheme--><font color="#996600"><span lang="EN-GB">Genetically Modified Foods for Human Health and 

  Nutrition: The Scientific Basis for Benefit/Risk Assessment</span><!--mstheme--></font></h3>

  <h4><!--mstheme--><font color="#333399">Executive Summary<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The purpose 

of this monograph is to provide an independent analysis of the scientific basis 

for assessing the benefits and risks of genetically modified (GM) crops and 

food, specifically in relation to their current and future impacts on human 

health and nutrition worldwide. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">One of the 

objectives of the International Council for Science (ICSU) is – </span></p>

<p class="iehbodydraft" style="margin-left:28.35pt;line-height:150%">

<span lang="EN-GB">‘to encourage and promote international scientific and 

technological activity for the benefit and well-being of humanity’</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">In 2000, two 

of ICSU’s member unions, the International Union of Nutritional Sciences (IUNS) 

and the International Union for Toxicology (IUTOX) initiated this present 

project on GM food (GMF) and GM crops for human health and nutrition, in order 

to contribute to the development of ICSU’s views on the applications of gene 

technology, and the relative risks and benefits involved. Four other ICSU member 

unions and two ISCU scientific committees, representing a breadth of scientific 

interests, joined in the project<a href="#_ftn1" name="_ftnref1" title style="color: blue; text-decoration: underline; text-underline: single"><span class="MsoFootnoteReference"><![if !supportFootnotes]><span lang="EN-GB" style="font-size: 12.0pt; font-family: Times New Roman">[1]</span><![endif]></span></a>.

</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">It is hoped 

that the findings of this project, combined with the outputs of other ICSU 

entities concerned with various aspects of gene technology, will enable ICSU to 

speak with authority on the scientific basis for understanding the risks and 

benefits of the uses of gene technology. </span></p>

<h4><!--mstheme--><font color="#333399">Structure of the monograph<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

monograph reflects the discussions at the final of three ICSU workshops 

organised to evaluate the scientific basis for the assessment of potential risks 

and benefits to human health and nutrition of the use of GMF crops. 

International experts in nutrition, medicine, toxicology, molecular biology, 

microbiology, genetics, economics and social science, including representatives 

of the science unions, participated in the workshop, which was held in 

Manchester, UK in May 2002. Prior to the meeting invited experts in relevant 

fields prepared working papers, which form the basis of Chapters 1 to 10 of the 

monograph. Each chapter was modified and finalised at the workshop in the light 

of discussions at the workshop. Only publicly available information and research 

results have been included in the monograph.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Chapter 1 

considers the role of science in the development and application of transgenic 

(genetic modification) technologies, in relation to the needs and concerns of 

society in general. Chapters 2 to 4 review topics pertaining to GM crops and 

food quality and human nutrition, improving agricultural practices, and 

industrial products and processes; Chapters 5 to 7 review GM fish, livestock, 

poultry, and microorganisms. Each of chapters 2 to 7 reviews, where appropriate, 

current knowledge on the expected or potential contribution of genetic 

modification technology, outcomes and impacts of the use of GM organisms (GMOs), 

standards of use, methods for the evaluation of outcomes and impacts, and 

knowledge gaps. Chapter 8 reviews the scientific basis for risk assessment of 

GMOs. Economic and social issues pertaining to the use and control of GMOs are 

reviewed in Chapter 9, and public attitudes towards GMFs are discussed in 

Chapter 10. Overall conclusions are outlined in Chapter 11. The monograph is 

intended to serve the increasing dialogue between society and science and thus 

contribute to ongoing discussions about the application of the technological 

innovations that make GMFs possible.</span></p>

<h4><!--mstheme--><font color="#333399">Addressing public concerns<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Public 

discussions about the ethical and socioeconomic issues surrounding the 

development and use of applications of modern biotechnology for agriculture are 

widespread, particularly discussions about the development of GMFs and GMOs and 

the safety and efficacy of the new products. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Public 

concerns about gene technology lie in four major areas, namely ethical concerns, 

socioeconomic issues, effects on the environment and food safety and human 

health. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Although 

acknowledging the importance and the interconnectivity of all these areas, the 

monograph’s principal focus is the scientific basis for assessing the risks and 

benefits to human health of GMFs and GM crops. It also seeks to identify ways in 

which knowledge gained from the health and nutrition sciences can contribute to 

the broad public debate, help clarify choices for individuals, communities and 

countries and inform policy development, while recognising that the context in 

which choices are made varies significantly with differences in societies, 

environments and economies across the world. In support of these aims the 

monograph also identifies gaps in knowledge where additional scientific research 

may help resolve uncertainties about safety, benefits, utility, acceptability 

and other aspects pertinent to the development and use of GMFs<b>. </b></span>

</p>

<h4><!--mstheme--><font color="#333399">Context <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The ideal 

relationship between scientists and society is one of dialogue amongst those who 

are mutually concerned with improving the human condition and minimising 

inequalities. Such dialogues must consider the values of diverse groups and 

identify the desirable balance between science directed at applied missions and 

science conducted for the sake of generating new knowledge.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The present 

biological revolution is based on a series of key discoveries in genetics, 

molecular biology and related fields. These include Mendel’s description in the 

late 19<sup>th</sup> century of the principles of genetic inheritance, Watson 

and Crick’s discovery in the 1950s of the double helix structure of DNA and the 

recent elucidation of the human genome. Developments associated with this 

continuum of discoveries have sometimes been responsive to dialogue between 

society and science. Successful exchanges are reflected in the early 

implementation of recombinant DNA technology in medicine. For example, many new 

pharmaceuticals, including new forms of insulin widely used by diabetics, are 

presently produced using new biotechnology. The present lack of consensus on 

appropriate uses of gene technology for the modifications of food and fibre 

crops is an example of a failure in exchange. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

monograph focuses on risks and benefits to human health, including the possible 

improvement of human nutrition, by transgenic modifications of plant and animal 

food sources. Its principal focus is the technological dimension of transgenic 

modifications. Other important issues are discussed where they illustrate the 

impact of setting technical priorities. Many of these other complex issues, such 

as any direct and indirect impacts of GMOs on the environment, bioethical 

considerations, and other social and economic concerns, are addressed more 

comprehensively elsewhere. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

monograph takes no position on appropriate policies that societies should adopt 

as a consequence of the scientific knowledge that is reviewed. It strives to 

assess scientific reliability, while recognising that quantifiable boundaries of 

(un)certainty are a defining characteristic of scientifically derived data. It 

is motivated by two global forces, mounting population pressures and rising 

quality-of-life expectations worldwide, and one principal assumption, namely 

that solutions and responses to the problems and challenges those forces present 

have technological dimensions. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Human health 

is not achievable unless adequate amounts of wholesome and safe foods are 

available and accessible during all life stages. The aim of ‘food-for-all’ is 

driven not only by humanitarian concerns but also by the biologic imperatives 

for achieving nutrient and food security that are linked to health and economic 

development. </span></p>

<h4><!--mstheme--><font color="#333399">Assumptions<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

monograph’s focus on the transgenic modification of plants and animals 

explicitly assumes that gene technology has the potential to achieve positive, 

dramatic, and useful results. The robustness of this assumption is tested 

throughout the monograph. Generally, arguments promoting the utility of 

transgenic technologies are based on the increased versatility and speed by 

which such modifications can be produced relative to traditional breeding 

techniques. This focus is not intended to imply that solutions and responses to 

the problems and challenges the future holds should be solely or even partially 

technological in nature. The only assertion made by this focus is that the 

technological dimension merits consideration along with others, for example 

economic policies such as those that govern global trade and agricultural 

subsidies. Most importantly, full accessibility to diverse, affordable, 

nutritionally adequate, wholesome diets remains the goal for all.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Two further 

assumptions are that the capabilities for exploiting technological possibilities 

enabled by current scientific advances must be available in the developing world 

and that transgenic modifications of plants and animals hold known and unknown 

risks, as do all technologies, old or new. Implicit in the latter assumption is 

that absolute safety is not an achievable standard. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">In the light 

of the above assumptions, it is essential to identify the following: the type 

and ‘magnitude’ of benefits and risks; who is likeliest to benefit from the 

application of specific technologies; to whom risks are likeliest to accrue; and 

the time frame for anticipated benefits and risks. The monograph explores how 

scientific knowledge can help answer these questions.</span></p>

<h4><!--mstheme--><font color="#333399">Benefits and risks associated with the products and process of transgenic 

modification<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Traditional 

breeding techniques have led to documented contributions to human nutrition of 

technologies based on genetic modification of plants and animals. Such successes 

include, in particular, applications that result in increased and more efficient 

production (i.e. improvements in productivity). Increases in food availability 

enabled by these advances have had significant health benefits. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">There are no 

known examples whereby the intentional modification of the composition of 

specific plant and animal foods through genetic techniques (traditional or 

modern) has resulted in documented improvements in human nutritional status at a 

population level. Transgenically modified plant foods currently in the food 

system were designed, for the most part, to achieve herbicide tolerance or 

resistance to pests. Other than fish, the development of transgenic animals 

intended for human consumption remains in the research and development phase.

</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">There is 

evidence that modification of plants by any process may result in increased 

risks to human health, owing to unexpected changes in the chemical composition 

of the plants. For example, in some cases, conventional plant breeding in celery 

and potato has increased levels of plant toxins. These changes are usually 

detected in the screening process, prior to the release of new plant varieties.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The current 

lack of clearly demonstrated benefits to consumers from the first generation of 

GM foods and conflicting opinions about the likelihood and potential 

significance of unintended adverse effects of transgenic modifications may have 

influenced views on their safety for human health and the environment. </span>

</p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Thus, the 

current debate about the ‘safety’ of transgenic foods needs reliable information 

on the safety of the results of genetic modifications, the safety of the 

inserted DNA itself, the potential risk of expressing gene products in another 

organism and the safety of the process itself. The monograph gives greatest 

attention to the predictability of effects of genetic modification on the 

composition of the product and to the risks and benefits to human health 

associated with compositional alterations in GMFs and GM crops.</span></p>

<h4><!--mstheme--><font color="#333399">Anticipated benefits and risks<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">

Transgenically modified plants and animals are projected to give rise to 

benefits and risks in two broad areas: health and the environment. Four 

categories of health benefits are recognised: enhancement of food security; 

enhancement of nutrient security; more targeted health benefits, such as 

immunisation; and reduction of diet related, adult-onset chronic diseases 

(through the manipulation of specific food components, e.g. manipulation of fat 

composition). Health risks associated with the approaches that are reviewed 

generally also fall into four categories – allergies, toxicities, nutrient 

imbalances, and decreasing diet diversity. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">

Environmental effects focus on the direct and indirect impact of GMOs and 

associated agricultural practices on the environment. These effects include 

potential negative and positive impacts on biodiversity, at the gene, species 

and ecosystem levels. For example, decreases in biodiversity may result from GM 

crops showing enhanced competitiveness in the field or from agricultural 

policies and economic pressures favouring the production of GM crops at the 

expense of other more genetically diverse alternatives. Changing agricultural 

practices may have beneficial, environmental effects. For example, environmental 

(and also health) benefits are likely when genetic modification of crops enables 

reduced insecticide use.</span></p>

<h4><!--mstheme--><font color="#333399">Determining what and how much information is needed <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Guidelines 

are useful to help determine the magnitude of effort that is appropriate to 

assure ‘reasonable certainty of no harm,’ and to trace foods through the 

production, processing, marketing, and distribution system. Several groups that 

have examined various facets of GMFs have included such guidelines, implemented 

with suitable flexibility, in their recommendations. Some proposed guidelines 

are as follows.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Actions should 

be proportionate to the nature of the potential risk</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Consistent 

precautionary limits should be applied in assessing all food products, 

irrespective of their production processes</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">More stringent 

limits should be applied to risks that are not easily reversible</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The extent to 

which precaution advances or detracts from relevant societal goals should be 

examined</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The costs that 

caution imposes should be considered</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Guidelines 

such as these are useful only if they are developed sufficiently so that the 

information needed for their effective application can be identified. 

Understanding what information is required, determining the limits of 

uncertainty that are appropriate to its derivation, and developing objective 

processes for the discovery of knowledge are all key areas that need the 

participation of science. However, it is equally clear that good science will 

not be enough, as each guideline incorporates dimensions that are broader than 

those normally encompassed by the scientific process.</span></p>

<h4><!--mstheme--><font color="#333399">Food quality and human nutrition<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Consumers in 

Europe and North America spend perhaps 10% of their income on food. The 

situation is very different in developing countries where poor consumers 

typically spend 70% of their income on food. The diets of the latter consist 

primarily of staple foods, which lack the vitamins and minerals necessary to 

sustain good health, whereas a range of foods (animal and fish products, fruits, 

pulses, and vegetables), rich in bioavailable vitamins and minerals or 

micronutrients, is necessary for good health and a productive life. 

Micronutrient malnutrition is widespread in poor countries, affecting more than 

one-half of the population in the developing world; women and children are 

particularly at risk. Except for pockets of extreme poverty and dislocations 

arising from natural disasters and situations of conflict, staple foods, such as 

cereals, roots and tubers, are generally available in sufficient supply. 

Although non-staple foods are also generally available, combinations of high 

prices and low purchasing power make them too expensive for many potential 

consumers. Low incomes also preclude poor people from access to competent health 

care. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">There are 

three broad ways that biotechnology may benefit consumers in developing 

countries. First, biotechnology offers a powerful, new tool to improve crop 

productivity, both by making conventional breeding faster and more efficient and 

by introducing new traits, by the insertion of novel genes in a crop species 

using transgenic methods. Second, pesticide applications may be reduced through 

adoption of pest and disease resistant crops; this can benefit the health of 

farmers, reduce input costs and benefit the environment. Third, biotechnology 

may improve the nutrition and health of consumers in developing countries 

through increasing the vitamin and mineral content of staples and other foods 

and/or by reducing allergens. Several such products are under development but 

none have been introduced commercially.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Possible 

biotechnology-based strategies should be considered in the context of 

alternative interventions that might help<b> </b>solve malnutrition and health 

problems in other ways. As one example, consideration of the relative costs of 

supplementation and commercial fortification programmes indicates that 

biofortification may be implemented for a fraction of the recurrent estimated 

costs of around US $200m per year for vitamin A supplements in developing 

countries. Consideration of the recent history of<b> </b>attempts to improve the 

micronutrient content of staple food crops using both biotechnology and 

conventional plant breeding is also informative; the example of rice serves to 

illustrate several key generic issues associated with using biotechnology to 

breed for new characteristics that may have benefits for consumers.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The optimal 

solution to micronutrient malnutrition in developing countries is a substantial 

improvement in dietary quality by higher consumption of pulses, fruits, 

vegetables, fish, and animal products. Realisation of this goal will require 

several inputs: (i) substantial investments by farmers, private businesses, and 

public agencies to build the infrastructure to produce and bring to market the 

requisite supply of non-staple foods;<br>

(ii) sound government policies to stimulate agricultural and economic growth; 

and <br>

(iii) considerable increases in the incomes of the poor during the course of 

economic development over many decades. In the meantime, breeding staple foods 

that are dense in minerals and vitamins could provide a low-cost, sustainable 

strategy for reducing existing levels of micronutrient malnutrition. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">However, 

such an approach requires that there should be no serious, negative agronomic 

consequences associated with the characteristic being added, that consumers’ 

quality preferences should be taken into account, and that the characteristic 

being added will result in a measurable improvement in the nutritional status of 

the malnourished, target population. The hazards associated with the various 

possible strategies should also be addressed.</span></p>

<h4><!--mstheme--><font color="#333399">Agricultural practice<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">New 

scientific developments in agricultural biotechnology are being used to increase 

the productivity of crops, primarily by reducing the costs of production by 

decreasing the needs for inputs of pesticides and herbicides, mostly in crops 

grown in temperate zones. New varieties of plants are being developed that 

should give higher yields with fewer inputs, can be grown in a wider range of 

environments, and provide both more nutritious harvested products and low-cost 

food supplies to consumers. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The traits 

these new plant varieties contain include insect resistance (cotton, maize), 

herbicide resistance (maize, soybean), and delayed fruit ripening (tomato). The 

benefits of these new crops are better weed and insect control, higher 

productivity, and more flexible crop management. These benefits accrue primarily 

to farmers and agribusinesses, although, by facilitating low-cost food 

production, there are also potential economic benefits for consumers. </span>

</p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Potential 

health benefits for consumers are also emerging from new varieties of corn and 

rapeseed with modified oil content, the benefits of which are especially 

relevant in developed countries. Other broader benefits to the environment and 

the community, in both developed and developing countries, come through reduced 

use of pesticides. Further crop/input trait combinations presently being 

field-tested, and of particular benefit to developing countries, include 

virus-resistant melon, papaya, potato, squash, tomato, and sweet pepper, 

insect-resistant rice, soybean, and tomato, disease-resistant potato, and 

delayed-ripening chilli pepper. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

development of crops resistant to biotic and abiotic stresses is critical for 

sustainable food production in the developing world. The use of GMF crops should 

go hand-in-hand with other technologies such as plant tissue culture, marker 

assisted breeding and conventional plant breeding. GMF crops could decrease the 

cost of production and have positive effects on the environment in both 

developed and developing countries. It is, however, prudent that the outcomes 

and impacts of the use of GMF crops are scientifically monitored with respect to 

farming efficiency, food production and environmental impacts.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

estimated global area of transgenic crops for 2001 is 52.6 million hectares 

grown by 5.5 million farmers in 13 countries. More than one quarter of the 

transgenic crop area in 2001 was grown in six developing countries. The number 

of farmers that planted GM crops increased from 3.5 million in 2000 to 5.5 

million in 2001. More than three-quarters of all farmers planting GM crops were 

resource poor farmers, mainly in China but also in South Africa, who planted 

cotton carrying an introduced <i>Bacillus thurigiensis</i> gene (<i>Bt</i> 

cotton), which confers insect resistance. The primary benefit of the 

introduction of <i>Bt</i> crops has been an increase in yield; however, a 

secondary benefit has been a decrease in the use of toxic chemical insecticides, 

for example by 60-80% in China. Such reduced insecticide use can be a major 

health benefit, especially in developing countries where spraying is usually by 

hand.</span></p>

<h4><!--mstheme--><font color="#333399">Industrial products and processes <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Industrial 

crops are those grown as sources of chemicals or components that serve non-food 

uses. Products derived from plants for industrial applications include oils, 

fibres, fuels and pharmaceuticals. Genetic modification of crops to improve 

industrial applications is relevant to human health because there are very few 

crops that are grown solely for industrial use and some parts of such crops 

could be consumed. For example, soybean is grown for both food and industrial 

oils, cotton is grown as a fibre crop but also produces seed oil for human and 

animal consumption, and maize is grown as a starch crop.</span></p>

<p class="iehbodydraft" style="line-height: 150%"><span lang="EN-GB">Although 

there are many GM crops for industrial applications under development, there are 

a limited number that have been introduced commercially. Soybean, cotton and 

maize are the major crops for which there are commercial GM varieties; currently 

Laurate Canola and High-Oleate Soybean are the only commercially available GM 

crops that have changes in composition that make them more useful for industry.

</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">A principal 

concern is how to use genetic modification technology in a way that gains the 

advantage of using renewable resources to replace products from petroleum and 

other non-renewable resources while maintaining a safe and adequate human food 

supply. It is also crucial to ensure that GM crops designed to produce 

industrial products do not inadvertently enter the human food chain or 

contaminate food crops with their transgenes, if these traits may pose a risk to 

the environment or to human health. Risk assessment of the ecological impact of 

crops grown to produce pharmaceuticals needs to be undertaken prior to their 

widespread cultivation.</span></p>

<h4><!--mstheme--><font color="#333399">Fish <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Many species 

of fin fish have been subjected to genetic modification. Although some of these 

are being considered for the food market, and for some regulatory approval is 

pending, no GM fish is known to be produced commercially for food at present<b>.</b> 

The main species that have been genetically modified are Atlantic salmon, coho 

salmon, common carp, tilapia, and channel catfish. Although the principal 

parameter modified to date is growth rate, other traits of interest include cold 

tolerance, disease resistance, and sterility.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">A number of 

factors should be considered in the risk assessment of the environmental impact 

of GM fish: the possibility that GM fish could escape from the physical 

containment under conditions of storm, flood, theft or human interference; 

survival of the fish in cold or warm water, and in salt, brackish or fresh 

water; whether the transgenic fish are sterile or partially sterile; the 

presence of wild fish of the same species in the surrounding waters; and whether 

the GM fish could become established as a novel pest species if they were to 

escape or be released.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Risk 

assessment for GM fish as consumer products also needs to consider several 

factors: the copy number of the transgene and the arrangement of the multiple 

copies; any evidence for insertional mutagenesis in any of the fish carrying the 

transgene; how many generations of fish have been produced; whether the food 

intake of the GM fish is different from the wild type; whether the physiology or 

anatomy of the fish is altered; any alteration in the texture and flavour of the 

fish; and whether the GM fish is more or less prone to known diseases of such 

fish species.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">GM fish may 

become important in the developing and industrial world as sources of protein, 

and may help meet the growing demand for fish cost-effectively. Nonetheless, 

consumer concerns related to food and environmental safety and ethical issues 

need to be incorporated into regulatory processes and commercialisation 

practices.</span></p>

<h4><!--mstheme--><font color="#333399">Livestock and poultry <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">No food 

product derived from GM livestock and poultry is currently under market 

production. Applications of transgenic technologies, with the main species of 

livestock and poultry, are now possible in two fields, namely agriculture and 

human healthcare. Agricultural applications focus on developing alternatives to 

current methods for animal breeding, with the potential added value of the 

ability to introduce genetic changes that cannot be achieved by other methods. 

Genetic modification technology could offer alternative production systems to 

fulfil demands for livestock that differ across geographical and socioeconomic 

regions of the world. Applications for human health are primarily targeted at 

healthcare products. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The risks 

associated with specific modifications will require analysis on a case-by-case 

basis, depending on the use of the GM product. New food products from livestock 

and poultry will require assessment in much the same way as GM plant products. 

The risks to the environment of GM livestock and poultry are considerably less 

than those potentially associated with GM plants or fish. There is a 

substantially lower likelihood of escape and dissemination of GM livestock and 

poultry, owing to the lack of competition with wild and related animals and bird 

species.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Methods 

involved in genetic modification of livestock and poultry are inefficient and 

expensive. Much research is still required to identify useful targets for 

genetic modification and to increase the overall efficiency of genetic 

modification methods, from frequency of production of transgenic animals to 

effective transgene expression. High costs mean there is little support from 

research funding agencies or from the relevant industries for development of the 

technology in relation to food production. In addition economic factors and 

public acceptability may inhibit the introduction of GM animals into the 

breeding stock of the animal breeding industries and dissemination to producers.

</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Potential 

hazards to humans, involved in production or when the products become part of 

the food chain, will require assessment through a regulatory process with 

appropriate licensing powers. These regulatory processes are already established 

in many countries, for example within the European Union. There are serious 

public concerns about the ethics of manipulating domesticated animals and about 

the animal welfare effects of genetic modifications. These should be considered 

and evaluated in a system that can be applied equally to animals and birds 

produced by genetic modification and to animals and birds produced by 

conventional breeding methods. </span></p>

<h4><!--mstheme--><font color="#333399">Microorganisms <!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">No 

genetically modified microorganism is currently used in foods although some are 

used to produce food ingredients. Microorganisms (bacteria, yeasts and 

filamentous fungi) can be used in food production as integral parts in 

preparation of various fermented foodstuffs or to produce food additives and 

processing aids (organic acids, flavouring agents, food enzymes etc.). In 

fermented foods the GM microorganisms (GMMs) can either be dead, inactivated or 

viable, leading to<b> </b>different safety implications. Owing<b> </b>to the 

plasticity of microbial genomes and the existing gene exchange mechanisms, 

genetic containment for GMMs represents a fundamentally different situation to 

that for other GMOs.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Food 

fermentation is an ancient practise and still valuable today. The successful 

application of GMMs in food fermentation is hampered by the lack of knowledge of 

the impact of specific genes on the fermentation process. This is particularly 

true with complex properties like aroma ripening and texture, which are often 

influenced by environmental factors. It might even be questionable whether 

genetic modification technology is the optimal methodology to improve many of 

the traditional processes; in many cases conventional strain selection and 

adjustment of the process will also be future methods of choice. Introduction of 

new, nutritionally valuable or health promoting properties into fermented foods 

by designed GMMs would be an attractive line of future research and product 

development. However, there are numerous areas of uncertainty, not least in the 

safety and regulatory aspects.</span></p>

<p class="iehbodydraft" style="line-height: 150%"><span lang="EN-GB">

Interactions of GMMs with host microflora and associated host-functions are 

critical for many of the eventual benefits and potential hazards. However, 

conventional microorganisms associated with fermented foods can also influence 

host microflora. The role and function of human microflora in health and disease 

are still poorly understood.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The safety 

assessment of any future GMM applications should be rigorous, as with other 

novel foods, while accepting that no food can be completely risk free. The 

identified hazards should be weighed against the expected benefits.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The safety 

evaluation of processing aids or food additives produced by GMMs should follow 

the same guidelines and practices applied to conventional products. However, 

special emphasis should be directed to the elimination of unintended effects 

each time a production organism or process has been modified, either by 

recombinant DNA techniques or conventional methods.</span></p>

<h4><!--mstheme--><font color="#333399">Regulation and risk assessment<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The safety 

assessment of GM food crops has attracted widespread attention. Regulatory 

principles and practises are in place in most developed and in several 

developing countries, and the Organisation for Economic Co-operation and 

Development (OECD) and the World Health Organization (WHO) in collaboration with 

the UN Food and Agriculture Organization (FAO) have published regulatory 

guidelines for GM foods. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Safety 

assessment of GM foods is carried out on a case-by-case basis, taking the 

specific modifications into account, and comparing the properties of the new 

food with those of the traditional counterpart. This comparative approach, 

applying the so-called principle of <i>substantial equivalence,</i> is based on 

the assumption that conventional foods are generally considered as safe for 

consumption, based on a history of use. Identified differences between the GM 

food and its counterpart are assessed with respect to their safety and 

nutritional implications for the consumer. The concept of substantial 

equivalence, as developed by the OECD and endorsed by the FAO/WHO, is a starting 

point for a safety evaluation and contributes to an adequate food safety 

assessment strategy. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Safety 

testing of whole foods is difficult. Generally assessment of ‘safety/toxicity’ 

relies on the description of dose–response relationships. It is not possible to 

produce similar information on whole foods using the conventional techniques 

used for chemicals. However, conventional tests reflect past technological 

possibilities and limitations, and new approaches for safety assessment of whole 

foods, taking advantage of modern molecular-biological, toxicological and 

analytical methods, are possible. </span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">There are 

concerns about the possibility of unintended consequences and the risks these 

represent, and present knowledge does support the likelihood of unanticipated 

compositional effects arising from the use of gene technology. However, it is 

emphasised that unintended effects do also occur in traditional plant breeding.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Present 

approaches to detecting expected and unexpected changes in the composition of GM 

food crops are primarily based on measurements of a limited selection of single 

compounds (targeted approach). In order to increase the possibility of detecting 

unintended effects, new profiling methods using gene expression technologies, 

proteomics and metabolomics, should be further developed and validated 

(non-targeted approach). Growing capabilities in proteomics and metabolomics 

permit increasingly comprehensive assessments of compositional changes. New 

approaches to safety testing are of particular interest for the safety and 

nutritional assessment of future GM crops with improved nutritional or health 

beneficial properties. However, the principal problems associated with advanced 

technologies for the determination of compositional changes lie not in the 

compositional analyses themselves, but in assessing the significance of the 

results of those analyses.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The 

comparative safety assessment approach should also be followed for the new 

generation of GMF crops in order to establish the degree of equivalence with 

presently available foods. The unmodified host organism may function as the 

relevant comparator for testing the degree of equivalence, but a possible 

outcome may be that a safety assessment of the new food <i>per se</i> is 

necessary. This may be the case for GM crops with extensive modification of 

existing metabolic pathways or addition of new ones, or for GM plants with 

decreased levels of naturally occurring toxins, which previously could not be 

used as food sources. Strategies should be designed on a case-by-case basis.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The use of 

post-marketing surveillance as an instrument to gain additional information on 

long-term effects of foods or food ingredients, either GMO-derived or 

traditional, should not be overestimated, given the multifactorial origin of 

many food-related diseases and the variability in genetic predisposition of the 

human population. Routine application in the food sector may yield limited 

information, and will be costly. Only in cases with specific biological 

end-points, for example allergenicity or food intolerance, or when exposure 

assessment is hampered by insufficient insight into the diets of specific 

consumer groups, do post-marketing surveillance strategies seem to be useful. 

Pre-market safety assessment of GM foods must provide sufficient safety 

assurance. </span></p>

<h4><!--mstheme--><font color="#333399">Socioeconomic aspects relevant to sustainability<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">The rapid 

adoption of GM crops has raised several ethical, ecological, economic and social 

concerns. Currently available GMOs may have both positive and negative effects 

on three indicators of sustainable agriculture and rural development, namely 

stocks of natural resources and environmental capital, efficiency and equity. 

The effects depend on the socioeconomic conditions underlying the<b> </b>

development, use and control of GMOs, including new crop varieties.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Three policy 

options are key to the sustainable development, use and control of GM foods, 

namely intellectual property protection, trade liberalisation and biosafety 

implementation. The effects of policy options that shape socioeconomic 

conditions are intricate; a policy option that directs socioeconomic conditions 

in one way may affect another policy option that leads in a different direction<b>

</b>(i.e. policy options in intellectual property, trade liberalisation and 

biosafety are sometimes mutually contradictory). Ensuring policy coherence is 

particularly challenging. </span></p>

<h4><!--mstheme--><font color="#333399">Societal issues and public attitudes<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Public 

perceptions and attitudes about emerging biosciences and other new technologies 

are critical determinants of how likely it is that the<b> </b>implementation and 

development<b> </b>of such technologies will succeed.</span></p>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">As well as 

considering the psychological determinants of people’s perceptions and 

attitudes, it is necessary to consider public trust in institutions, both those 

concerned with regulatory matters and those concerned with the strategic 

development of science. While it is important to develop best practice in 

science communication pertinent to the risks and benefits of GMFs, this alone 

will not increase public confidence in gene technology. Rather, it is also 

important to consider new ways to involve members of the public explicitly in 

the debate about technology innovation and commercialisation and to improve the 

relationship and dialogue between science and society. Improved dialogue needs 

to be a two way process that makes a difference to policy development and 

regulatory practice.<i> </i></span></p>

<h4><!--mstheme--><font color="#333399">Overall conclusions<!--mstheme--></font></h4>

<p class="iehbodydraft" style="line-height:150%"><span lang="EN-GB">Considering 

the reviews of current knowledge in the monograph as a basis for expert opinions 

and projections about the development, use and risk assessment of GMFs for human 

health and nutrition, workshop participants reached a number of overall 

conclusions, as outlined below.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Categories of risk</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -21.25pt; line-height: 150%; margin-left: 21.25pt; margin-right: 0in; margin-top: 0in; margin-bottom: .0001pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>

</span><span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The 

process of the development of transgenic organisms presents no new categories of 

risk compared with conventional methods for improving plants, animals or 

microorganisms. However, specific traits introduced by either approach might 

pose unique risks, which need to be identified.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Food quality and human nutrition</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The potential 

benefits of improving the nutritional quality of foods are higher for low&#8209;income 

countries, where food budgets account for two-thirds or more of total 

expenditures and where poor dietary quality and micronutrient malnutrition are 

widespread. Most consumers in rich countries have access to a relatively 

inexpensive supply of safe and healthy food. </span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol; color: black">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Nutritional and 

quality traits of foods can be altered through transgenic methods. A large 

number of products are under development and testing.<span style="color:black">

</span></span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol; color: black">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The nutritional 

efficacy of these products and risks of unintended harmful effects have yet to 

be tested and demonstrated.<span style="color:black"> </span></span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol; color: black">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The commercial 

viability of these products has yet to be demonstrated.<span style="color:black">

</span></span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; ">

The sustainable solution to malnutrition in developing countries is provision of 

a sufficient quantity of high quality diet, which the poor desire but presently 

cannot afford. During the long-term process of achieving this goal, 

biofortification is a low-cost strategy, which complements other technological 

and social interventions – assuming that the nutritional efficacy and commercial 

viability can be established. </span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Agricultural practice </font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The development 

of crops resistant to biotic and abiotic stresses is critical for sustainable 

food production in the developing world. The use of GMF crops should go 

hand-in-hand with other technologies such as plant tissue culture, marker 

assisted breeding and conventional plant breeding.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">GMF crops could 

decrease the cost of production and have positive effects on the environment in 

both developed and developing countries.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">It is, however, 

prudent that the outcomes and impacts of the use of GMF crops are scientifically 

monitored with respect to farming efficiency, food production and environmental 

impacts.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Gaps in 

knowledge about GMF crops include their efficacy compared with conventionally 

bred varieties with similar traits and potential direct and indirect effects on 

the environment, such as their risks of invasiveness, their impact on non-target 

organisms and possible unintended effects. Some of these gaps may be filled by 

new technologies under development and by continuing ecological research.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Industrial products and processes</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Crops can be 

genetically modified to produce oils, starch, fibre, protein or other chemicals 

useful for industrial processes. For example, soybean oil, with high oleate 

content, and canola oil, rich in laurate, are both being produced commercially 

using these methods.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">A principal 

concern is how to use genetic modification technology in a way that gains the 

advantage of using renewable resources to replace products from petroleum and 

other non-renewable resources while maintaining a safe and adequate human food 

supply.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">It is also 

crucial to ensure that GM crops designed to produce industrial products but not 

registered for human use do not inadvertently enter the human food chain or 

contaminate food or other crops with their transgenes.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Fish</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">GM fin fish of a 

variety of species have been produced, many involving the use of model fish for 

fundamental research, although some of the modifications are applicable to 

species important in aquaculture.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The present and 

projected increasing demand for fish suggests that GM fish may become important 

in future in both the developed and developing worlds. However this will only be 

possible if consumer acceptance is achieved.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Livestock and poultry</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Food products 

derived from GM livestock and poultry are far from commercial use. </span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The methods 

involved are presently inefficient and expensive. There are significant issues 

for the introduction of GM animals into breeding stock and dissemination to 

producers.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Potential 

hazards to humans, involved in production or when products become part of the 

food chain, will require assessment through a regulatory process with 

appropriate licensing powers.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">There are 

serious public concerns about the ethics of manipulating domesticated animals 

and the possible welfare effects.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Microorganisms</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">At present no 

GMMs are used commercially in food fermentations; however, many enzymes produced 

by GMMs are routinely used in the food industry.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The safety 

evaluation of GMM-derived food additives and processing aids should follow the 

same guidelines and practices as the conventional products; however special 

emphasis should be placed on the detection of possible unintended effects.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Regulation and risk assessment</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Safety 

assessment of GM foods is carried out on a case-by-case basis, taking the 

specific modification features into account, and comparing the properties of the 

new food with those of the traditional counterpart. This comparative approach, 

applying the so-called principle of substantial equivalence, is based on the 

assumption that conventional foods are generally considered as safe for 

consumption, based on a history of use. Identified differences between the GM 

food and its counterpart are assessed with respect to their safety and 

nutritional implications for the consumer. The concept of substantial 

equivalence is a starting point for a safety evaluation and contributes to an 

adequate food safety assessment strategy. </span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Safety testing 

of whole GM foods needs improvement. The use of specific <i>in vitro</i> models 

and new methods such as DNA microarray technologies may elucidate mechanisms of 

action and interactions of biologically active compounds in food.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Present 

approaches to detecting expected and unexpected changes in the composition of GM 

food crops are primarily based on a targeted approach (measuring a limited 

selection of single compounds). In order to increase the possibility of 

detecting unintended effects a non-targeted approach (using new technologies 

such as the gene expression technologies – proteomics and metabolomics) can be 

used.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The usefulness 

of post-market surveillance to obtain information on long-term effects of foods 

or food ingredients, either GMO-derived or traditional, should not be 

overestimated, given the multifactorial origin of many food-related diseases and 

the variability in genetic predisposition of the human population. It may be 

useful in cases with specific biological outcomes, for example allergenicity or 

food intolerance, or when the exposure assessment provides insufficient insight 

into the diets of specific consumer groups.</span></p>

<h4><!--mstheme--><font color="#333399">Socioeconomic considerations<!--mstheme--></font></h4>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The currently 

available GMOs are suggested to have both positive and negative effects on three 

indicators of sustainable agriculture and rural development. These are stocks 

(of natural resources and environmental capital</span><span lang="EN-GB">)</span><span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">, 

efficiency and equity. These bilateral effects depend on the socioeconomic 

conditions underlying the development, use and control of GMOs. </span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">The three key 

policy options that shape socioeconomic conditions are intellectual property 

protection, trade liberalisation and biosafety implementation. The effects of 

applying these options on the socioeconomic conditions are very intricate, as 

optimising one option may have contrary effects on the other options and thus on 

the socioeconomic conditions.</span></p>

<h5><!--mstheme--><font color="#006633"><u><font size="3">Societal issues and public attitudes</font></u><!--mstheme--></font></h5>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Communication 

activities need to take account of the factors driving public concern, which may 

be different in different countries. This should include taking account of 

cross-cultural differences in information needs, if appropriate. In particular, 

discussion of ethical issues and effective communication about known and 

potential uncertainties and unintended effects must be addressed.</span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%; font-family: Symbol">

·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>

<span lang="EN-GB" style="font-size: 12.0pt; line-height: 150%">Failure to 

consult the public about policy development leads to a loss of public confidence 

in science and technology. The purpose of such consultations is to make a 

difference to policy development. </span></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

&nbsp;</p>

<!--msthemeseparator--><p align="center"><img src="../_themes/nature-iuns/anarule.gif" width="600" height="10"></p>

<p class="iehbullets" style="text-indent: -17.0pt; line-height: 150%; margin-left: 17.0pt">

    <a href="#_ftnref1" name="_ftn1" title style="color: blue; text-decoration: underline; text-underline: single">

    <span class="MsoFootnoteReference"><span lang="EN-GB"><![if !supportFootnotes]>

    <span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">

    [1]</span><![endif]></span></span></a><span lang="EN-GB"><font size="2"> 

    International Union of Biochemistry and Molecular Biology (IUBMB), 

    International Union of Food Science and Technology (IUFoST), International 

    Union of Pure and Applied Chemistry (IUPAC), International Union of Soil 

    Science (IUSS), Advisory Committee on Genetic Experimentation and 

    Biotechnology (ACOGEB; formerly Steering Committee on Genetics and 

    Biotechnology (SCGB)) and Committee on Sciences for Food Security (CSFS)</font></span></p>



<!--mstheme--></font><!--msnavigation--></td></tr><!--msnavigation--></table><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td><!--mstheme--><font face="Trebuchet MS, Arial, Helvetica">



<p>



<script language="JavaScript"><!--
if(MSFPhover) { MSFPnav17n=MSFPpreload("../_derived/back_cmp_nature-iuns110_back.gif"); MSFPnav17h=MSFPpreload("../_derived/back_cmp_nature-iuns110_back_a.gif"); }
// --></script><a href="sciences_for_food_security.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav17'].src=MSFPnav17h.src" onmouseout="if(MSFPhover) document['MSFPnav17'].src=MSFPnav17n.src"><img src="../_derived/back_cmp_nature-iuns110_back.gif" width="100" height="20" border="0" alt="Back" align="middle" name="MSFPnav17"></a> <script language="JavaScript"><!--
if(MSFPhover) { MSFPnav18n=MSFPpreload("../_derived/next_cmp_nature-iuns110_next.gif"); MSFPnav18h=MSFPpreload("../_derived/next_cmp_nature-iuns110_next_a.gif"); }
// --></script><a href="obesity/obesity.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav18'].src=MSFPnav18h.src" onmouseout="if(MSFPhover) document['MSFPnav18'].src=MSFPnav18n.src"><img src="../_derived/next_cmp_nature-iuns110_next.gif" width="100" height="20" border="0" alt="Next" align="middle" name="MSFPnav18"></a>

</p>



<!--mstheme--></font></td></tr><!--msnavigation--></table></body>




<!-- Mirrored from www.iuns.org/features/executive_summary.htm by HTTrack Website Copier/3.x [XR&CO'2010], Wed, 11 Jan 2012 10:10:34 GMT -->
</html>